Emerald Advisers’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2014
Q1
Sell
-78,545
Closed -$5.08M 388
2013
Q4
$5.08M Sell
78,545
-83,952
-52% -$5.43M 0.28% 122
2013
Q3
$10.3M Buy
162,497
+14,265
+10% +$904K 0.58% 60
2013
Q2
$6.22M Buy
+148,232
New +$6.22M 0.38% 92